Mining Awareness | 10 Sep 2021
“In summary, our results reveal that selection pressure in a highly vaccinated community (>71% fully vaccinated as of early August 2021) favors more infectious, antibody-resistant VOCs such as the gamma12,32 and delta12,13,21,25 variants, and that high-titer symptomatic post-vaccination infections may be a contributor to viral spread.” (Servellita et al, 2021)
Evidence presented in the article, below, suggests that even if you believe in the Covid-19 vaccines, that mass vaccination was a very big mistake, which is undermining vaccine effectiveness. Further mass vaccination can only make things worse.
If you believe in the Covid-19 vaccines, then the evidence, presented in this article, suggests that only very at-risk individuals should have been vaccinated – such as institutionalized frail elderly people. Mass vaccination appears to be undermining the effectiveness of the vaccines for those who would need them the most.
Mass vaccination appears to be driving vaccine resistant varieties, and more contagious varieties. This can be but exacerbated by the fact that there are so many new Americans and permanent residents, who maintain ties to India, China, etc., and continue to travel back and forth importing new resistant varieties.
Most people are familiar with antibiotic resistant strains of bacteria and warnings against over-use and misuse of antibiotics. The phenomenon described below appears to be similar.
Note: only you can and should make decisions about your own individual health. This includes vaccines. Each body is unique. Don’t allow yourself to be bullied one way or the other by anyone. It’s your life and you must live or die with the consequences of your choices. Choose wisely. Don’t tell anyone else what to do, either. You become responsible for that decision right or wrong.
However, from a public health perspective, mass vaccination with these experimental vaccines was, and is, a very bad idea. This is true even if the vaccines are ever proven safe.
Please save a copy of the article. It may never pass peer review because academia rarely likes truth, but loves money. Pharmaceutical companies have plenty of money. Of course, there’s lots of money to be made with Covid tests, too.
Article: “Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California
Venice Servellita, Mary-Kate Morris, Alicia Sotomayor-Gonzalez, Amelia S. Gliwa, Erika Torres, Noah Brazer, Alicia Zhou, Katherine T. Hernandez, Madeline Sankaran, Baolin Wang, Daniel Wong, Candace Wang, Yueyuan Zhang, Kevin R Reyes, Dustin Glasner, Xianding Deng, Jessica Streithorst, Steve Miller, Edwin Frias, John Hackett Jr., Carl Hanson, Debra Wadford, Susan Philip, Scott Topper, Darpun Sachdev, Charles Y. Chiu
doi: https://doi.org/10.1101/2021.08.19.21262139
This article is a preprint and has not been peer-reviewed.
https://www.medrxiv.org/content/10.1101/2021.08.19.21262139v1
Abstract
Associations between vaccine breakthrough cases and infection by SARS coronavirus 2 (SARS-CoV-2) variants have remained largely unexplored. Here we analyzed SARS-CoV-2 whole-genome sequences and viral loads from 1,373 persons with COVID-19 from the San Francisco Bay Area from February 1 to June 30, 2021, of which 125 (9.1%) were vaccine breakthrough infections. Fully vaccinated were more likely than unvaccinated persons to be infected by variants carrying mutations associated with decreased antibody neutralization (L452R, L452Q, E484K, and/or F490S) (78% versus 48%, p = 1.96e-08), but not by those associated with increased infectivity (L452R and/or N501Y) (85% versus 77%, p = 0.092). Differences in viral loads were non-significant between unvaccinated and fully vaccinated persons overall (p = 0.99) and according to lineage (p = 0.09 – 0.78). Viral loads were significantly higher in symptomatic as compared to asymptomatic vaccine breakthrough cases (p < 0.0001), and symptomatic vaccine breakthrough infections had similar viral loads to unvaccinated infections (p = 0.64). In 5 cases with available longitudinal samples for serologic analyses, vaccine breakthrough infections were found to be associated with low or undetectable neutralizing antibody levels attributable to immunocompromised state or infection by an antibody-resistant lineage. These findings suggest that vaccine breakthrough cases are preferentially caused by circulating antibody-resistant SARS-CoV-2 variants, and that symptomatic breakthrough infections may potentially transmit COVID-19 as efficiently as unvaccinated infections, regardless of the infecting lineage.
